Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain

Studies about the survival of patients with prostate cancer by stage or risk of progression are scarce. The aims of this study were (1) to determine the cause-specific survival by risk in prostate cancer patients in Mallorca diagnosed in the period 2006–2011; (2) to identify the factors that explain...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Juan José Montaño, Antoni Barceló, Paula Franch, Jaume Galceran, Alberto Ameijide, Jaime Pons, Maria Ramos
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	prostate neoplasm survival stage multiple imputation Medicine R
Acceso en línea:	https://doaj.org/article/1553e1b46dee4a88aaf7d158d15388ac
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1553e1b46dee4a88aaf7d158d15388ac
record_format	dspace
spelling	oai:doaj.org-article:1553e1b46dee4a88aaf7d158d15388ac2021-11-11T16:18:31ZProstate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain10.3390/ijerph1821111561660-46011661-7827https://doaj.org/article/1553e1b46dee4a88aaf7d158d15388ac2021-10-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/21/11156https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601Studies about the survival of patients with prostate cancer by stage or risk of progression are scarce. The aims of this study were (1) to determine the cause-specific survival by risk in prostate cancer patients in Mallorca diagnosed in the period 2006–2011; (2) to identify the factors that explain and predict the likelihood of survival and the risk of dying from this type of cancer; and (3) to determine the distribution of prostate cancer by risk in the patients in Mallorca diagnosed in the period 2006–2011. Incident prostate cancer cases diagnosed between 2006 and 2011 were identified through the Mallorca Cancer Registry. We collected age; date and method of diagnosis; date of follow-up or death; T, N, M and stage according to the TNM 7th edition; Gleason score; prostate-specific antigen (PSA); histology according to the International Classification of Diseases for Oncology (ICD-O) 3rd edition, comorbidities and treatments. We calculated risk in four categories: low, medium, high and very high. The end point of follow-up was 31 December 2014. Multiple imputation (MI) was performed to estimate cases with unknown risk. We identified 2921 cases. Five years after diagnosis, survival after MI was 89% globally, and was 100% for low-risk cases, 96% for medium risk, 93% for high risk and 69% for very-high-risk cases. Cases with histology other than adenocarcinoma, with high (and especially very high) risk, as well as with systemic, mixed and observation/unspecified treatments had worse prognoses.Juan José MontañoAntoni BarcelóPaula FranchJaume GalceranAlberto AmeijideJaime PonsMaria RamosMDPI AGarticleprostate neoplasmsurvivalstagemultiple imputationMedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 11156, p 11156 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	prostate neoplasm survival stage multiple imputation Medicine R
spellingShingle	prostate neoplasm survival stage multiple imputation Medicine R Juan José Montaño Antoni Barceló Paula Franch Jaume Galceran Alberto Ameijide Jaime Pons Maria Ramos Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain
description	Studies about the survival of patients with prostate cancer by stage or risk of progression are scarce. The aims of this study were (1) to determine the cause-specific survival by risk in prostate cancer patients in Mallorca diagnosed in the period 2006–2011; (2) to identify the factors that explain and predict the likelihood of survival and the risk of dying from this type of cancer; and (3) to determine the distribution of prostate cancer by risk in the patients in Mallorca diagnosed in the period 2006–2011. Incident prostate cancer cases diagnosed between 2006 and 2011 were identified through the Mallorca Cancer Registry. We collected age; date and method of diagnosis; date of follow-up or death; T, N, M and stage according to the TNM 7th edition; Gleason score; prostate-specific antigen (PSA); histology according to the International Classification of Diseases for Oncology (ICD-O) 3rd edition, comorbidities and treatments. We calculated risk in four categories: low, medium, high and very high. The end point of follow-up was 31 December 2014. Multiple imputation (MI) was performed to estimate cases with unknown risk. We identified 2921 cases. Five years after diagnosis, survival after MI was 89% globally, and was 100% for low-risk cases, 96% for medium risk, 93% for high risk and 69% for very-high-risk cases. Cases with histology other than adenocarcinoma, with high (and especially very high) risk, as well as with systemic, mixed and observation/unspecified treatments had worse prognoses.
format	article
author	Juan José Montaño Antoni Barceló Paula Franch Jaume Galceran Alberto Ameijide Jaime Pons Maria Ramos
author_facet	Juan José Montaño Antoni Barceló Paula Franch Jaume Galceran Alberto Ameijide Jaime Pons Maria Ramos
author_sort	Juan José Montaño
title	Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain
title_short	Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain
title_full	Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain
title_fullStr	Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain
title_full_unstemmed	Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain
title_sort	prostate cancer survival by risk and other prognostic factors in mallorca, spain
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/1553e1b46dee4a88aaf7d158d15388ac
work_keys_str_mv	AT juanjosemontano prostatecancersurvivalbyriskandotherprognosticfactorsinmallorcaspain AT antonibarcelo prostatecancersurvivalbyriskandotherprognosticfactorsinmallorcaspain AT paulafranch prostatecancersurvivalbyriskandotherprognosticfactorsinmallorcaspain AT jaumegalceran prostatecancersurvivalbyriskandotherprognosticfactorsinmallorcaspain AT albertoameijide prostatecancersurvivalbyriskandotherprognosticfactorsinmallorcaspain AT jaimepons prostatecancersurvivalbyriskandotherprognosticfactorsinmallorcaspain AT mariaramos prostatecancersurvivalbyriskandotherprognosticfactorsinmallorcaspain
_version_	1718432338754404352

Prostate Cancer Survival by Risk and Other Prognostic Factors in Mallorca, Spain

Ejemplares similares